3-Methylmethcathinone

3-Methylmethcathinone
Clinical data
ATC code none
Legal status
Legal status
Identifiers
CAS Number 1246816-62-5 N
ChemSpider 34445939
UNII 7QY1MH15BG YesY
Chemical and physical data
Formula C11H15NO
Molar mass 177.24 g/mol
3D model (Jmol) Interactive image

3-Methylmethcathinone, also known as 3-MMC and 3-Mephedrone,[1] is a designer drug from the substituted cathinone family, with Empathogen-entactogen effects. 3-MMC is closely related in structure to the popular illicit drug mephedrone (4-MMC), and is illegal in most countries that have banned 3-mephedrone as it is a structural isomer of 4-mephedrone. However 3-MMC has still appeared on the "legal high" market as an alternative to mephedrone, and was first identified being sold in Sweden in 2012.[2] Unlike other legal highs 3-MMC was tested and characterized in large mammals,[3] providing much more knowledge about it than other substances.

Legal Status

As of October 2015 3-MMC is a controlled substance in China.[4]

3-MMC is banned in the Czech Republic.[5]

References

  1. Preedy, Victor. Neuropathology of Drug Addictions and Substance Misuse Volume 2: Stimulants, Club and Dissociative Drugs, Hallucinogens, Steroids, Inhalants and International Aspects (2 ed.). London: KIng's College. ISBN 978-0-12-800212-4.
  2. EMCDDA 2012 Annual report on the state of the drugs problem in Europe
  3. Shimshoni, J. A.; Britzi, M.; Sobol, E.; Willenz, U.; Nutt, D.; Edery, N. (24 March 2015). "3-Methyl-methcathinone: Pharmacokinetic profile evaluation in pigs in relation to pharmacodynamics". Journal of Psychopharmacology. 29 (6): 734–743. doi:10.1177/0269881115576687.
  4. "关于印发《非药用类麻醉药品和精神药品列管办法》的通知" (in Chinese). China Food and Drug Administration. 27 September 2015. Retrieved 1 October 2015.
  5. "Látky, o které byl doplněn seznam č. 4 psychotropních látek (příloha č. 4 k nařízení vlády č. 463/2013 Sb.)" (PDF) (in Czech). Ministerstvo zdravotnictví.


This article is issued from Wikipedia - version of the 9/20/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.